Potent and specific small molecule stabilizers of amyloidogenic antibody light chains

Ended Project Grant Awarded Last action

Award ID
F31HL154732
Recipient
Awarding agency
Obligated
$102,893

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Place of performance
California, USA

Award details come from USAspending.gov.

About this award

The Scripps Research Institute received a $102,893 Project Grant award from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute on February 17, 2021 to develop potent and specific small molecule stabilizers of amyloidogenic antibody light chains. The grant supports research under the Cardiovascular Diseases Research program (CFDA #93.837), which aims to foster basic, translational, clinical and population sciences research on heart and vascular diseases through competitive grants and research training. The Scripps Research Institute will use the funding over the November 30, 2022 performance period to conduct research stabilizing amyloidogenic antibody light chains, which can accumulate and form harmful deposits. The grant aims to develop small molecule therapies to potentially treat amyloid-related cardiovascular conditions.

Transactions

Action Obligated Date
Amendment $0
Amendment $2,869
Amendment $2,869
Amendment $2,869
Amendment $30,883
Amendment $30,883
Original award $32,520

Quick answers

Who received award F31HL154732?

F31HL154732 was awarded to Scripps Research Institute by National Heart Lung and Blood Institute (National Institutes of Health) on February 17, 2021.

How much is award F31HL154732 worth?

$102,893 has been obligated on F31HL154732.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award